Cash and cash equivalents were $2.3M as of December 31, 2022, compared to $12.7M as of December 31, 2021.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACER:
- Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
- Biotech Alert: Searches spiking for these stocks today
- Acer Therapeutics: Data presented at SIMD on Urea Cycle Disorders
- Acer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder Treatment Attributes
- Acer Therapeutics prices $2.68M registered direct offering